Log in

NYSE:BAX - Baxter International Stock Price, Forecast & News

$93.06
-0.10 (-0.11 %)
(As of 02/21/2020 01:20 AM ET)
Today's Range
$92.41
Now: $93.06
$93.50
50-Day Range
$83.62
MA: $89.69
$93.30
52-Week Range
$72.42
Now: $93.06
$95.00
Volume1.78 million shs
Average Volume2.59 million shs
Market Capitalization$47.51 billion
P/E Ratio31.33
Dividend Yield0.94%
Beta0.96
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.13 billion
Cash Flow$4.65 per share
Book Value$14.69 per share

Profitability

Net Income$1.62 billion

Miscellaneous

Employees50,000
Market Cap$47.51 billion
Next Earnings DateN/A
OptionableOptionable

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.


Baxter International (NYSE:BAX) Frequently Asked Questions

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, February 18th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.22 per share on Wednesday, April 1st. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date is Thursday, February 27th. View Baxter International's Dividend History.

How will Baxter International's stock buyback program work?

Baxter International announced that its board has approved a share buyback program on Tuesday, November 13th 2018, which permits the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 6.1% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's management believes its shares are undervalued.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) announced its earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a net margin of 13.80% and a return on equity of 22.99%. Baxter International's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.64 EPS. View Baxter International's Earnings History.

What price target have analysts set for BAX?

17 Wall Street analysts have issued 12 month price objectives for Baxter International's stock. Their forecasts range from $75.00 to $109.00. On average, they expect Baxter International's share price to reach $94.00 in the next year. This suggests a possible upside of 1.0% from the stock's current price. View Analyst Price Targets for Baxter International.

What is the consensus analysts' recommendation for Baxter International?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Has Baxter International been receiving favorable news coverage?

Media stories about BAX stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Baxter International earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned media headlines about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Baxter International.

Are investors shorting Baxter International?

Baxter International saw a increase in short interest in January. As of January 31st, there was short interest totalling 6,470,000 shares, an increase of 45.1% from the January 15th total of 4,460,000 shares. Based on an average trading volume of 3,060,000 shares, the days-to-cover ratio is currently 2.1 days. Approximately 1.3% of the shares of the company are short sold. View Baxter International's Current Options Chain.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Cisco Systems (CSCO), BlackRock (BLK), Verizon Communications (VZ), Honeywell International (HON), AT&T (T), Pfizer (PFE), Alibaba Group (BABA) and Abbott Laboratories (ABT).

Who are Baxter International's key executives?

Baxter International's management team includes the folowing people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 48)
  • Mr. Scott Pleau, Sr. VP of Operations (Age 53)

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional investors include Wealth Quarterback LLC (14.07%), State Street Corp (4.68%), Third Point LLC (3.43%), FMR LLC (2.64%), Geode Capital Management LLC (1.41%) and Caisse DE Depot ET Placement DU Quebec (1.34%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

Which major investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bessemer Group Inc., Schroder Investment Management Group, Bank of New York Mellon Corp, AQR Capital Management LLC, Janus Henderson Group PLC, Los Angeles Capital Management & Equity Research Inc. and Argent Capital Management LLC. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

Which major investors are buying Baxter International stock?

BAX stock was bought by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Capital International Investors, Bank of Montreal Can, Third Point LLC, Alyeska Investment Group L.P., New York State Common Retirement Fund, PGGM Investments and Stifel Financial Corp. View Insider Buying and Selling for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $93.06.

How big of a company is Baxter International?

Baxter International has a market capitalization of $47.51 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

What is Baxter International's official website?

The official website for Baxter International is http://www.baxter.com/.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (NYSE BAX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  659 (Vote Outperform)
Underperform Votes:  578 (Vote Underperform)
Total Votes:  1,237
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel